Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.2%

11 terminated/withdrawn out of 510 trials

Success Rate

89.0%

+2.4% vs industry average

Late-Stage Pipeline

10%

53 trials in Phase 3/4

Results Transparency

0 of 89 completed trials have results

Key Signals

96 recruiting6 withdrawn

Enrollment Performance

Analytics

N/A

184(63.0%)

Phase 2

34(11.6%)

Phase 4

31(10.6%)

Phase 3

22(7.5%)

Early Phase 1

12(4.1%)

Phase 1

9(3.1%)

292Total

N/A(184)

Phase 2(34)

Phase 4(31)

Phase 3(22)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (510)

Showing 20 of 510 trials

NCT07849348Not ApplicableNot Yet Recruiting

Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria

Role: collaborator

NCT07766434Recruiting

A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation

Role: collaborator

NCT07836244Completed

Predicting the Outcome of ADHD in White Matter Injure Neonates With Multi-modality MRI

Role: lead

NCT05759572Phase 2Active Not Recruiting

Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer

Role: collaborator

NCT07383909Not ApplicableRecruiting

Remote Ischemic Preconditioning for Aute Type A Aortic Dissection Surgery

Role: collaborator

NCT06654453Not ApplicableRecruiting

Manual Thrombus Aspiration During PCI in STEMI With Angiographically Evident Thrombus

Role: collaborator

NCT07389460Phase 3Recruiting

Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)

Role: lead

NCT06125847Early Phase 1Recruiting

NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia

Role: lead

NCT07796113Phase 2Recruiting

Adebrelimab With Famitinib and Chemotherapy as Neoadjuvant Therapy for ESCC

Role: lead

NCT05198154Active Not Recruiting

ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC

Role: collaborator

NCT07660458Withdrawn

Parental Distress and Treatment Adherence in Pediatric Recurrent Medulloblastoma

Role: collaborator

NCT07767994Phase 2Not Yet Recruiting

AK112 Combined With GAP Conversion Therapy for Locally Advanced Gallbladder Cancer

Role: lead

NCT07757282Recruiting

Peripheral Blood Lipidomic and Ceramide Profiles in Atrial Fibrillation

Role: lead

NCT05818098Not ApplicableCompleted

Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR)

Role: collaborator

NCT05813704Not ApplicableCompleted

Coronary Crossing System in Patients With Coronary Chronic Total Occlusions

Role: collaborator

NCT05767164Not ApplicableRecruiting

Correlation Between Parameters and Prognosis of Cervical Single Open-door Surgery

Role: collaborator

NCT05487417Phase 4Completed

Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy

Role: collaborator

NCT07730619Active Not Recruiting

To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing Relapse

Role: lead

NCT05824923Phase 3Active Not Recruiting

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

Role: collaborator

NCT05957523Not ApplicableRecruiting

Effects of Remote Ischemic Preconditioning on Peripheral Blood Biomarkers in Healthy Adults (EMINENT)

Role: lead